Drug news
FDA approves Lyrica (Pfizer) for management of pain associated with Spinal Cord Injury
The FDA has approved the use of Lyrica (pregabalin) capsules CV from Pfizer for the management of Neuropathic Pain associated with Spinal Cord Injury. Lyrica received a priority review designation for this new indication from the FDA. More than 100,000 patients � approximately 40 percent of the 270,000 patients with Spinal Cord Injury in the United States - suffer from this chronic, complex pain condition. Neuropathic pain associated with Spinal Cord Injury can be severely debilitating and may significantly hinder rehabilitation and the ability to regain function.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins